Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors Life Science Investing
Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants Life Science Investing
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics Life Science Investing
Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
